The global vascular graft market size was valued at $4,993.64 million in 2020, and is projected to reach $8,138.68 million by 2030, registering a CAGR of 4.98% from 2021 to 2030. A vascular graft is a surgical procedure that redirects blood flow from one area of the body to another by reconnecting blood vessels. Vascular grafts are used for the surgery of vascular diseases. Vascular disease includes any condition that affects normal blood circulatory system, such as peripheral artery disease (PAD), abdominal aortic aneurysm (AAA), carotid artery disease (CAD), arteriovenous malformation (AVM), critical limb-threatening ischemia (CLTI), pulmonary embolism (blood clots), deep vein thrombosis (DVT), chronic venous insufficiency (CVI), and varicose veins.
The growth of the global vascular grafts market is majorly driven by increase in vascular diseases, such as atherosclerosis, pulmonary embolism, deep vein thrombosis, and other cardiac disorders as well as increase in number of hospitals and surgery centers, which boost the diagnosis and treatment of diseases. For instance, according to the report of the American Heart Association, in 2019, 197.2 million people lived with ischemic heart disease (IHD). In addition, increase in cardiovascular disorders is one of the key drivers of the market. According to the World Health Organization (WHO), an estimated 17.9 million people died from cardiovascular diseases (CVDs) in 2019.
Moreover, advancements in vascular disease devices are anticipated to contribute toward the growth of the market. In addition, new product launches in market further boost the market growth. However, product failure and product recalls are expected to restrict the market growth during the forecast period.
Global Vascular Graft Market Segmentation
The vascular graft market is segmented on the basis of product, raw material, and end users. By product, the market is mainly categorized into hemodialysis access graft, endovascular aneurysm repair stent grafts, and peripheral vascular graft. Endovascular aneurysm repair stent grafts are further subcategorized into abdominal aortic aneurysm (AAA) and thoracic aortic aneurysm (TAA). By raw material, it is categorized in polyester, polytetrafluoroethylene (PTFE), polyurethane, and biosynthetic. By end users, it is divided into hospitals and ambulatory surgical centers (ASCs).
By region, the vascular graft market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, South Arabia, South Africa, and LAMEA).
On the basis of product, the hemodialysis access graft segment dominated the vascular grafts market in 2020, and this trend is expected to continue during the forecast period, owing to increase in cardiovascular diseases. However, the endovascular aneurysm repair stent grafts segment is expected to witness considerable growth during the forecast period, owing to advancements in endovascular grafts therapy.
On the basis of raw material, the polyurethane segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to reliability of polyester material. However, the inhaled biosynthetic segment is expected to witness considerable growth during the forecast period, due to development of advanced biosynthetic materials.
On the basis of end users, the hospitals segment was the major contributor in 2020 and is expected to maintain its lead during the forecast period, owing to increase in number of hospitals. However, the inhaled ambulatory surgical centers (ASCs) segment is expected to witness considerable growth during the forecast period, due to rise in number of ambulatory surgical centers.
On the basis of region, North America garnered the major share in the vascular graft market in 2020, and is expected to dominate the global market during the forecast period, owing to the rise in prevalence of cardiac diseases, presence of key players for manufacturing of vascular grafts, and well-established infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR of xx% from 2021 to 2030, owing to increase in the number of hospitals, increase in cardiac surgeries, and high population.
The key players operating in the global vascular graft market include B. Braun Melsungen AG, Becton, Dickinson And Company, Cook Medical, Inc., Cordis, Endologix Inc., Getinge Group, LeMaitre Vascular Inc., Medtronic plc, Terumo Medical Corporation, and W. L. Gore & Associates, Inc.
For more information: https://www.alliedmarketresearch.com/vascular-graft-market